Single-cell genomics · Spatial Transcriptomics · Bioinformatics · Analysis Software · ComparisonSources read 17 October 2026
From sequencer files to results, without code
Six single-cell analysis platforms, compared
Six commercial platforms turn single-cell, spatial and bulk sequencing data into results without programming: Illumina’s Partek Flow and its cloud successor Connected Multiomics, Parse Biosciences’ Trailmaker, 10x Genomics’ Cloud Analysis and its new Sentira, BioTuring’s suite, and ROSALIND. None of them covers every chemistry and every data type. Two questions sort them: which kit made the data, and whether it is single-cell, imaging-based spatial or bulk. Around them, 2025 and 2026 moved the ground. QIAGEN bought Parse; a jury found Parse infringed patents licensed to a 10x subsidiary, while an appeals court upheld the invalidation of three of 10x’s own; 10x tightened its free quota and announced a paid platform for 2027; and a company named Rosalind, Inc. signed a non-binding term sheet over its platform assets.
What Happened
What is established, and how firmly Each item with its standing first, read at filings, court reporting and the vendors’ own pages on 17 October 2026.
- $231.0Mcash QIAGEN reports paying for Parse Biosciences, completed 2 December 2025
- 5 / 50free 10x Cloud analyses per dataset, and per month, since 8 July 2025
- >$4.8Mjury damages against Parse, as announced by 10x on 28 August 2026
- early 2027when 10x expects Sentira Spatial to become a paid, credit-based platform
| Standing | What | Read at |
|---|---|---|
| Confirmed: filing | QIAGEN acquired 100% of Parse Biosciences on 2 December 2025. Cash consideration $231.0 million, of which $33.0 million held in escrow; contingent payments of up to $55.0 million through 2027. The purchase-price allocation is still preliminary. At the announcement on 4 November 2025 the upfront figure was about $225 million. | QIAGEN’s half-year report and its announcement, both filed with the SEC |
| Confirmed: filing | Made in USA Inc. reported a non-binding term sheet, signed 23 March 2026, with a company named Rosalind, Inc., to form Rosalind Systems, Inc. from Rosalind’s platform assets and intellectual property. The filing says there is no assurance the deal will be completed. No later filing completing it was found by 17 October 2026. | Form 8-K, SEC |
| Confirmed: court record, as reported | On 19 August 2026 the Federal Circuit affirmed three Patent Trial and Appeal Board decisions that found the challenged claims of three 10x Genomics patents unpatentable as obvious, on petitions Parse filed. | IPWatchdog |
| Confirmed: vendor documentation | 10x Cloud Analysis allows 5 free analyses per dataset and 50 per calendar month, whichever is hit first, a cap added on 8 July 2025. Beyond them an analysis costs $5.00, plus $0.02 per GB at 200 GB of input or more; paid use is offered only in the United States and Canada. | 10x billing page and release notes |
| Confirmed: vendor documentation | Connected Multiomics reached full commercial release (v1.0) on 4 December 2025 and was announced on 6 January 2026. Illumina still sells Partek Flow, describing it as the on-premises stand-alone option. | Illumina release notes, press release and product page |
| Confirmed: vendor documentation | Since May 2026 a 10x Cloud account can be connected to BioTuring, sending data across; customers new to BioTuring get a 30-day free trial, as the two companies announced on 26 January 2026. | 10x support tutorial; BioTuring’s release |
| Confirmed, as announced by a party | On 28 August 2026, as 10x announced it, a jury in the District of Delaware found Parse wilfully infringed three patents exclusively licensed to Scale Biosciences, part of 10x since 2025, and awarded over $4.8 million on Evercode Whole Transcriptome sales from February 2021 to 30 June 2026 at a 14% royalty. 10x says it will seek enhanced damages and a permanent US injunction; neither has been decided in any source read. | 10x press release |
| Confirmed, as announced by a party | 10x announced Sentira on 29 September 2026, starting with Sentira Spatial: free through early access for Xenium and Atera users, then a paid platform with consumption-based credits from early 2027. A single-cell module is listed as coming soon, with no date. | 10x press release and product page |
| Vendor claim, not independently verified | Sentira cuts analysis cycles “from hours … to minutes” (10x and NVIDIA); BioTuring’s algorithms “accelerate discovery up to 1,000×”; Connected Multiomics “can aggregate thousands of multiomic samples”. No independent benchmark of any of them was found. | 10x, BioTuring and Illumina releases |
| Not public | Sentira’s price; Partek Flow’s, Connected Multiomics’ and BioTuring’s prices; when Sentira’s single-cell module arrives. | — |
What is settled
Who owns which platform, what each one accepts, and what 10x Cloud and ROSALIND charge are all stated in filings or the vendors’ own documentation.
What is not
Whether an injunction follows the Delaware verdict, whether the Rosalind term sheet becomes a deal, and what Sentira will cost. And no source compares the platforms’ speed or accuracy independently.
Timeline
Two years that reshaped the field Dated by the document that carries each item.
- 16 Jan 2024Parse Biosciences acquires Biomage, host of the largest community instance of Cellenics, an open-source platform developed at Harvard Medical School’s Department of Biomedical Informatics.
- 30 May 2024Trailmaker launches, already used by over 4,500 researchers, free to Parse customers and all academic researchers.
- 9 Jun 202510x Cloud adds multi-sample integration with SCTransform and Harmony.
- 8 Jul 202510x Cloud adds a monthly cap of 50 free analyses and prices paid analyses by input size.
- 25 Sep 2025BioTuring and the Human Cell Atlas make HCA atlases explorable in Talk2Data, on NVIDIA DGX B200 systems.
- 16 Sep 2025ROSALIND’s founder, chief executive since 2013, calls “data intelligence” “not a product name, but a direction”.
- 20 Oct 202510x Cloud opens a prompt-based interface for AI assistants.
- 4 Nov 2025QIAGEN agrees to acquire Parse for about $225 million upfront, with up to $55 million in milestones.
- 2 Dec 2025QIAGEN completes the acquisition: 100% of the shares, $231.0 million in cash.
- 4 Dec 2025Connected Multiomics v1.0, full commercial release.
- 6 Jan 2026Illumina announces Connected Multiomics, after a year with 40 early-access users.
- 26 Jan 2026BioTuring and 10x announce a collaboration: 30 days’ free access for 10x customers new to BioTuring.
- 19 Feb 2026Connected Multiomics v1.1 adds AI-assisted task recommendations.
- 23 Mar 2026Made in USA Inc. signs the non-binding term sheet with Rosalind, Inc.; reported in its filing of 31 March.
- 14 Apr 2026ROSALIND’s founder describes the “Rosalind Corpus” and “Rosalind Data Intelligence” as “a direction we’re building”, naming no release date.
- May 2026The 10x Cloud to BioTuring connection goes live.
- 2 Jun 2026Connected Multiomics v1.2 adds eQTL and pQTL analysis and an AI-written methods summary.
- 19 Aug 2026Federal Circuit affirms the PTAB: challenged claims of three 10x patents are unpatentable as obvious.
- 28 Aug 2026Delaware jury finds Parse wilfully infringed three Scale-licensed patents; over $4.8 million, as 10x announced it.
- 24 Sep 2026Connected Multiomics v1.3: a read-only question-and-answer tool and “Smart Suggestions”.
- 29 Sep 202610x announces Sentira; Sentira Spatial free in early access, paid from early 2027.
What cannot be dated. When Sentira’s single-cell module will arrive, and what Sentira will cost; whether the Rosalind term sheet becomes a signed agreement; the outcome of 10x’s post-trial requests in Delaware; and how long Illumina will support Partek Flow beside its cloud successor. None of the sources read gives a date for any of them.
The Argument
No platform does everything, and three questions sort them What each vendor says its platform is for, against what its documentation says it accepts.
Upstream or downstream
Turning reads into a matrix is a different job from interpreting it
- 10x Cloud runs 10x’s own pipelines — Cell Ranger, Space Ranger, the multiome and immune-profiling variants — and returns matrices and Loupe Browser files.
- Trailmaker does both: its Pipeline module aligns and counts, its Insights module interprets.
- Partek Flow, Connected Multiomics, BioTuring and ROSALIND are mainly where a matrix becomes clusters, cell types, differential expression and pathways.
Whose chemistry
Each vendor’s own kit is served first by its own software
- 10x Cloud and Sentira take only 10x data. Trailmaker’s Pipeline takes only Parse Evercode short-read FASTQ.
- Trailmaker’s Insights module, though, imports 10x, BD Rhapsody, Seurat and AnnData files; Partek Flow documents Visium, Xenium and CosMx imports; BioTuring’s SpatialX names CosMx, Xenium, Visium HD and MERSCOPE.
- ROSALIND centres on sequencing assays plus NanoString’s nCounter and GeoMx, and calls itself Bruker’s preferred nCounter solution; Bruker runs training on it.
Where data lives
Storage and hosting decide what an institution may use
- Trailmaker stores uploads on AWS servers in Ireland and deletes FASTQ files 30 days after upload.
- Partek Flow can run on a customer’s own server; NIH runs it on its Biowulf cluster. UNC’s cloud instance is not approved for any human or clinical data — one institution’s rule, not the product’s.
- Outside the United States and Canada, 10x Cloud users get the free quota only, and must download within 90 days.
| Platform | What its maker says it is for | Read at |
|---|---|---|
| Partek Flow | “Researchers of all skill levels”; bulk, single-cell, spatial, ChIP and ATAC, DNA, metagenomics, arrays; the on-premises option. | Illumina product page |
| Connected Multiomics | “The next evolution of Partek Flow”: cloud, multiomic, with DRAGEN and AI-assisted variant interpretation. | Illumina webinar page and press release |
| Trailmaker | Guiding the analysis of Evercode data “from FASTQ files to figures”. | Trailmaker user guide |
| 10x Cloud | Running 10x pipelines in the cloud, free within quota; data handed on to BioTuring. | 10x billing page and tutorial |
| Sentira | From data generation “to experimental conclusions”; GPU-accelerated; Spatial first, Single Cell “coming soon”. | 10x press release and product page |
| BioTuring | No-code, GPU-accelerated spatial and single-cell analysis; a curated database of 700M+ cells queried in plain language. | BioTuring product pages |
| ROSALIND | Analysis, interpretation and collaboration for biologists; meta-analysis across 50+ knowledge bases; nCounter and GeoMx. | ROSALIND store and blog |
A reading
Reading. The first thing to settle is not which platform is best but which kit made the data and which type it is. Vendor lock-in is strongest upstream, where each pipeline reads only its own chemistry; downstream, three of the six read other vendors’ formats.
What complicates it
Every figure about speed or scale on these pages is the vendor’s own, and no independent head-to-head benchmark of the six was found. That is a finding about the search, not proof that none exists.
What Others Add
What each platform accepts, where it runs, and what it costs From each platform’s own documentation, read on 17 October 2026.
| Platform | Single-cell | ATAC / multiome | Spatial | Bulk | Other vendors’ data |
|---|---|---|---|---|---|
| Partek Flow | Yes | Yes | Visium, Xenium, CosMx | Yes | Yes |
| Trailmaker | Yes | Not documented | Not documented | Not documented | Downstream only |
| 10x Cloud | 10x only | 10x multiome | Visium HD | No | No |
| Sentira | Coming soon | Not stated | Xenium, Atera | Not stated | No |
| BioTuring | Yes | Not checked | CosMx, Xenium, Visium HD, MERSCOPE | Yes (SmartBulk) | Yes |
| ROSALIND | Yes | Bulk ATAC only | GeoMx | Yes, a core use | Sequencing and nCounter |
| Platform | Runs where | AI features | Price |
|---|---|---|---|
| Partek Flow | Illumina-hosted, or on the customer’s own cloud or server | None stated | By quote; single-cell/spatial and pathway are add-ons |
| Connected Multiomics | Cloud | Task suggestions, AI methods summary, variant interpretation, a read-only Q&A tool | Not read |
| Trailmaker | Cloud, AWS in Ireland | A help chatbot with no access to user data | Free for Parse customers and academics |
| 10x Cloud | Cloud | Automated cell-type annotation; a prompt-based interface | Free quota; then from $5.00 an analysis |
| Sentira | Cloud, GPU | Agentic single-cell analysis listed as coming soon | Free in early access; credits from early 2027 |
| BioTuring | Cloud; a notebook workbench that draws on private servers | Plain-language queries; an MCP engine that shows its code | No price published |
| ROSALIND | Cloud | A stated direction, with no release date | Academic from $208 a month, billed annually |
| Published price | Amount |
|---|---|
| 10x Cloud, analysis beyond the free quota, input under 200 GB | $5.00 |
| 10x Cloud, input of 200 GB or more: $5.00 plus $0.02 per GB (300 GB comes to $11.00) | $5.00 + $0.02/GB |
| 10x Cloud, storage beyond 90 days, per GB a month | $0.02 |
| 10x Cloud, downloads beyond 150% of output, per GB | $0.10 |
| ROSALIND Academic Researcher, 1 seat, 250 GB, a month billed annually | $208 |
| ROSALIND Academic Team, 2 seats, 1 TB, a month billed annually | $416 |
| ROSALIND, each extra Team seat, a month | $125 |
The steps inside the downstream half. Trailmaker’s guided processing filters cells on mitochondrial fraction, gene and transcript counts and doublets before it integrates samples; 10x Cloud added SCTransform and Harmony integration in June 2025. Those quality-control thresholds decide which cells an experiment keeps, and how far the defaults hold across tissues is the subject of the filters that decide what a single-cell experiment saw. Trailmaker lets the processed Seurat or AnnData object be downloaded, so the same cells can be taken into other tools; whether Partek Flow runs a user’s own R or Python scripts could not be established from the pages read.
Vendor figures, read as such
Talk2Data’s 700M+ cells (298.8M of them human), Sentira’s hours-to-minutes and Connected Multiomics’ thousands of samples are each company’s own statement.
Not established here
Where 10x Cloud stores data; BioTuring’s free academic terms, prices and export formats; ROSALIND’s security certifications and hosting; any platform’s GxP or 21 CFR Part 11 support. Each is a question to put to the vendor in writing.
Conclusion
Which platform suits which lab One card per platform: who it is for, what it is best at, and the trade-off.
Partek Flow / Connected Multiomics
Cores and translational groups running many data types
- Trade-off: no published price, single-cell and pathway tools sold separately, and a cloud successor that leaves Partek Flow’s support horizon unstated.
Trailmaker
Parse users and academic labs
- Trade-off: upstream it reads Parse kits only, spatial and ATAC workflows are not documented, and the owner is in patent litigation with 10x in both directions.
10x Cloud
Every 10x user, for the processing step
- Trade-off: 10x data only, a processing service rather than a full downstream workbench, and paid use only in the United States and Canada.
Sentira
Xenium and Atera users, to evaluate now
- Trade-off: spatial only for now, a price not announced, and no public details on security or export in the pages read.
BioTuring
Groups with large imaging-spatial datasets, and pharma data teams
- Trade-off: no published price, several product names to tell apart, and performance claims that are the company’s own.
ROSALIND
nCounter and GeoMx users, bulk RNA-seq teams, CROs
- Trade-off: no imaging single-cell spatial support listed, and a non-binding term sheet over its platform assets still open.
Hold loosely
Prices and quotas change; this is how they stood on 17 October 2026. Sentira’s cost, the Delaware injunction request and the Rosalind term sheet are all open, and no independent benchmark ranks the six.
- Reading. A small academic lab using only 10x Chromium: process in 10x Cloud, then go further in Trailmaker’s Insights module, which imports Cell Ranger output and is free to academics.
- Reading. Parse Evercode users: Trailmaker from FASTQ to figures, including TCR and BCR kits.
- Reading. A core running bulk, single-cell, ATAC and spatial work: Partek Flow where data must stay on site, Connected Multiomics where DRAGEN and the cloud fit; ask Illumina in writing how long Partek Flow will be supported.
- Reading. Large imaging-spatial studies across technologies: BioTuring’s SpatialX, with its 30-day trial for 10x customers new to it.
- Reading. Xenium or Atera users: try Sentira while it is free, and keep another route ready until its 2027 price is known.
- Reading. nCounter, GeoMx or bulk RNA-seq teams: ROSALIND, with data-export and change-of-control terms in the contract.
- Reading. Teams with bioinformaticians: pair any platform with Seurat or Scanpy and prefer the ones that hand back an object those tools can open.
Quick notes
- Illumina, press release of 6 Jan 2026 (via Nasdaq), Partek Flow product page, the Partek Flow Next Chapter webinar page, Connected Multiomics release notes, and Partek Flow documentation on Xenium, CosMx and single-cell import
- NCI Center for Cancer Research, Partek Flow at NIH
- UNC School of Medicine BARC, Partek Flow
- Parse Biosciences, releases of 16 Jan 2024 and 30 May 2024, and the Trailmaker user guide
- Harvard Medical School DBMI, Cellenics
- QIAGEN, Exhibit 99.2 to Form 6-K (4 Nov 2025) and half-year report for 2026 (Form 6-K), SEC EDGAR
- 10x Genomics, releases of 28 Aug 2026 and 29 Sep 2026 (PR Newswire), Sentira product page, and Cloud Analysis billing page, release notes and BioTuring connection tutorial
- IPWatchdog, 19 Aug 2026
- BioTuring, releases of 25 Sep 2025 and 26 Jan 2026, and the Talk2Data, SpatialX and BioStudio pages
- ROSALIND, store page and blog posts of 16 Sep 2025, 14 Apr 2026 and 9 May 2026
- Made in USA Inc., Form 8-K of 31 Mar 2026, SEC EDGAR
- Bruker Spatial Biology, event listing of 15 Aug 2024. Read 17 October 2026.
Reliable
Worth believing
Sharing a subject
- The Filters That Decide What a Single-Cell Experiment SawBioinformatics · Single-cell genomics
- Seven sequence aligners, three jobsAnalysis Software · Bioinformatics
- sc-SPLASH — Reference-Free Discovery in Barcoded Single-Cell SequencingSingle-cell genomics
- Bruker’s spatial biology division: NanoString, Canopy and AcuitySpatial Transcriptomics
- Small Variants in the Long-Read EraBioinformatics
Sharing a source domain
- Bruker’s spatial biology division: NanoString, Canopy and Acuity10xgenomics.com · brukerspatialbiology.com · prnewswire.com · sec.gov
- Sequencing a Genome at Home — The Full ONT MinION Workflowillumina.com
- The Claude Code Quality Postmortem — Three Unrelated Changesgithub.com
- Local LLMs and Buying a Mac — A Technical Reportgithub.com
- 9 Billion Requests a Day, Moved Without Rebuilding a Filegithub.com
- Grok Build Shipped Whole Repos to xAI's Cloudgithub.com
- Avalanche's RWA Boom, and Why AVAX Need Not Followgithub.com
- Jingye vs Britain — British Steel Compensation Claimprnewswire.com
- Five Names for One Stack, and No Agreed Ordergithub.com
- High Bandwidth Flash Gets Its First Standardprnewswire.com
- The Longer the Name, the Bigger the Thing Being Soldprnewswire.com
- Enough, or Less? Context Engineering Said Both in One Weekgithub.com
- It Began as Tuning an Agent. By March It Meant Everything but the Model.github.com
- One Term, Coined Twice, Two Weeks Apart. The Joke Won.github.com
- Dorado v4 to v6 — What Changed, How Much, and Whether It Was Goodgithub.com
- Same Shock, Two Balance Sheetssec.gov
- Nvidia's Record $96.2 Billion Quartersec.gov
- The Filters That Decide What a Single-Cell Experiment Sawparsebiosciences.com
- Z.ai's Chinese-Chip Claim for GLM-5.3-Flashprnewswire.com
- Shunting Bulk Reads to a Cheaper Model — What the 90% Actually Cutsgithub.com
- Forty-Three Years Was Last Month’s Pricegithub.com
- A Chain of Its Own, and the Bill It Still Payssec.gov
- Seven sequence aligners, three jobsgithub.com
- REST, SOAP, gRPC, GraphQL and MCP: pick by who callsgithub.com